527 related articles for article (PubMed ID: 22448619)
1. Impact of obesity on drug metabolism and elimination in adults and children.
Brill MJ; Diepstraten J; van Rongen A; van Kralingen S; van den Anker JN; Knibbe CA
Clin Pharmacokinet; 2012 May; 51(5):277-304. PubMed ID: 22448619
[TBL] [Abstract][Full Text] [Related]
2. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Anderson GD
Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
[TBL] [Abstract][Full Text] [Related]
4. A mechanistic approach for the scaling of clearance in children.
Edginton AN; Schmitt W; Voith B; Willmann S
Clin Pharmacokinet; 2006; 45(7):683-704. PubMed ID: 16802850
[TBL] [Abstract][Full Text] [Related]
5. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.
Alcorn J; McNamara PJ
Clin Pharmacokinet; 2002; 41(13):1077-94. PubMed ID: 12403644
[TBL] [Abstract][Full Text] [Related]
6. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
Kim SB; Kim KS; Kim DD; Yoon IS
Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
[TBL] [Abstract][Full Text] [Related]
7. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
[TBL] [Abstract][Full Text] [Related]
8. Influence of obesity on drug disposition.
Blouin RA; Kolpek JH; Mann HJ
Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
[TBL] [Abstract][Full Text] [Related]
9. Effect of obesity on the pharmacokinetics of drugs in humans.
Hanley MJ; Abernethy DR; Greenblatt DJ
Clin Pharmacokinet; 2010; 49(2):71-87. PubMed ID: 20067334
[TBL] [Abstract][Full Text] [Related]
10. Effects of obesity on the cytochrome P450 enzyme system.
Kotlyar M; Carson SW
Int J Clin Pharmacol Ther; 1999 Jan; 37(1):8-19. PubMed ID: 10027478
[TBL] [Abstract][Full Text] [Related]
11. Estimating pediatric doses of drugs metabolized by cytochrome P450 (CYP) isozymes, based on physiological liver development and serum protein levels.
Suzuki S; Murayama Y; Sugiyama E; Hirunpanich V; Saito K; Sekiyama M; Sato H
Yakugaku Zasshi; 2010 Apr; 130(4):613-20. PubMed ID: 20372009
[TBL] [Abstract][Full Text] [Related]
12. Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes.
Zhang T; Krekels EHJ; Smit C; Knibbe CAJ
Expert Opin Drug Metab Toxicol; 2022 Oct; 18(10):657-674. PubMed ID: 36217846
[TBL] [Abstract][Full Text] [Related]
13. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
14. Drug disposition in obesity: toward evidence-based dosing.
Knibbe CA; Brill MJ; van Rongen A; Diepstraten J; van der Graaf PH; Danhof M
Annu Rev Pharmacol Toxicol; 2015; 55():149-67. PubMed ID: 25340929
[TBL] [Abstract][Full Text] [Related]
15. Estimating the glomerular filtration rate in obese adult patients for drug dosing.
Pai MP
Adv Chronic Kidney Dis; 2010 Sep; 17(5):e53-62. PubMed ID: 20727504
[TBL] [Abstract][Full Text] [Related]
16. The influence of sex on pharmacokinetics.
Schwartz JB
Clin Pharmacokinet; 2003; 42(2):107-21. PubMed ID: 12537512
[TBL] [Abstract][Full Text] [Related]
17. Developmental pharmacokinetics.
Anderson GD
Semin Pediatr Neurol; 2010 Dec; 17(4):208-13. PubMed ID: 21183126
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Obesity on Drug Metabolism in Children.
Oeser SG; Rougee LR; Collier AC
Drug Metab Lett; 2015; 9(2):88-98. PubMed ID: 26411468
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M; Bekersky I; Blum RA; Tolbert D
Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
[TBL] [Abstract][Full Text] [Related]
20. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
McGinnity DF; Parker AJ; Soars M; Riley RJ
Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
